Evidence map›Paper›PMID 26258815›Full record

ArticlePloS one2015

Islet Oxygen Consumption Rate (OCR) Dose Predicts Insulin Independence in Clinical Islet Autotransplantation.

Klearchos K Papas, Melena D Bellin, David E R Sutherland, Thomas M Suszynski, Jennifer P Kitzmann, Efstathios S Avgoustiniatos, Angelika C Gruessner, Kathryn R Mueller, Gregory J Beilman, Appakalai N Balamurugan and 8 more

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Islets-on-Chip: A Tool for Real-Time Assessment of Islet Function Prior to Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Article
  11. Article
  12. Article
  13. Clinically available immunosuppression averts rejection but not systemic inflammation after porcine islet xenotransplant in cynomolgus macaques.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Analysis of Non-Human Primate Pancreatic Islet Oxygen Consumption.Journal of visualized experiments : JoVE · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Klearchos K PapasInstitute for Cellular Transplantation, Department of Surgery, University of Arizona, Tucson, Arizona, United States of America; Department of Surgery, University of Minnesota, Minneapolis, Minnesota, United States of America; Schulze Diabetes Institute, Minneapolis, Minnesota, United States of America.
Melena D BellinDepartment of Surgery, University of Minnesota, Minneapolis, Minnesota, United States of America; Schulze Diabetes Institute, Minneapolis, Minnesota, United States of America.
David E R SutherlandDepartment of Surgery, University of Minnesota, Minneapolis, Minnesota, United States of America; Schulze Diabetes Institute, Minneapolis, Minnesota, United States of America.
Thomas M SuszynskiDepartment of Surgery, University of Minnesota, Minneapolis, Minnesota, United States of America; Schulze Diabetes Institute, Minneapolis, Minnesota, United States of America.
Jennifer P KitzmannInstitute for Cellular Transplantation, Department of Surgery, University of Arizona, Tucson, Arizona, United States of America; Department of Surgery, University of Minnesota, Minneapolis, Minnesota, United States of America; Schulze Diabetes Institute, Minneapolis, Minnesota, United States of America.
Efstathios S AvgoustiniatosDepartment of Surgery, University of Minnesota, Minneapolis, Minnesota, United States of America; Schulze Diabetes Institute, Minneapolis, Minnesota, United States of America.
Angelika C GruessnerInstitute for Cellular Transplantation, Department of Surgery, University of Arizona, Tucson, Arizona, United States of America.
Kathryn R MuellerInstitute for Cellular Transplantation, Department of Surgery, University of Arizona, Tucson, Arizona, United States of America; Department of Surgery, University of Minnesota, Minneapolis, Minnesota, United States of America; Schulze Diabetes Institute, Minneapolis, Minnesota, United States of America.
Gregory J BeilmanDepartment of Surgery, University of Minnesota, Minneapolis, Minnesota, United States of America.
Appakalai N BalamuruganDepartment of Surgery, University of Minnesota, Minneapolis, Minnesota, United States of America; Schulze Diabetes Institute, Minneapolis, Minnesota, United States of America.
Gopalakrishnan LoganathanDepartment of Surgery, University of Minnesota, Minneapolis, Minnesota, United States of America; Schulze Diabetes Institute, Minneapolis, Minnesota, United States of America.
Clark K ColtonDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Maria KoulmandaThe Transplant Institute, Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, Boston, Massachusetts, United States of America.
Gordon C WeirJoslin Diabetes Center, Boston, Massachusetts, United States of America.
Josh J WilhelmDepartment of Surgery, University of Minnesota, Minneapolis, Minnesota, United States of America; Schulze Diabetes Institute, Minneapolis, Minnesota, United States of America.
Dajun QianInformation Science, City of Hope, Duarte, California, United States of America.
Joyce C NilandInformation Science, City of Hope, Duarte, California, United States of America.
Bernhard J HeringDepartment of Surgery, University of Minnesota, Minneapolis, Minnesota, United States of America; Schulze Diabetes Institute, Minneapolis, Minnesota, United States of America.

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR000114 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$35.0M
Institutional Career Development CoreKL2TR002492 · NCATS · UNIVERSITY OF MINNESOTA · PI INGBAR, DAVID H · 2018 to 2022
$6.3M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)KL2TR000113 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$5.4M
Sitagliptin therapy to improve outcomes after islet autotransplantation.K23DK084315 · NIDDK · UNIVERSITY OF MINNESOTA · PI BELLIN, MELENA D. · 2010 to 2014
$816k
NCATS NIH HHS KL2 TR000113NCATS NIH HHS UL1 TR000114NIDDK NIH HHS K23 DK084315NIDDK NIH HHS P30 DK036836
6 · The paper itself

Abstract

backgroundReliable in vitro islet quality assessment assays that can be performed routinely, prospectively, and are able to predict clinical transplant outcomes are needed. In this paper we present data on the utility of an assay based on cellular oxygen consumption rate (OCR) in predicting clinical islet autotransplant (IAT) insulin independence (II). IAT is an attractive model for evaluating characterization assays regarding their utility in predicting II due to an absence of confounding factors such as immune rejection and immunosuppressant toxicity.

methodsMembrane integrity staining (FDA/PI), OCR normalized to DNA (OCR/DNA), islet equivalent (IE) and OCR (viable IE) normalized to recipient body weight (IE dose and OCR dose), and OCR/DNA normalized to islet size index (ISI) were used to characterize autoislet preparations (n = 35). Correlation between pre-IAT islet product characteristics and II was determined using receiver operating characteristic analysis.

resultsPreparations that resulted in II had significantly higher OCR dose and IE dose (p<0.001). These islet characterization methods were highly correlated with II at 6-12 months post-IAT (area-under-the-curve (AUC) = 0.94 for IE dose and 0.96 for OCR dose). FDA/PI (AUC = 0.49) and OCR/DNA (AUC = 0.58) did not correlate with II. OCR/DNA/ISI may have some utility in predicting outcome (AUC = 0.72).

conclusionsCommonly used assays to determine whether a clinical islet preparation is of high quality prior to transplantation are greatly lacking in sensitivity and specificity. While IE dose is highly predictive, it does not take into account islet cell quality. OCR dose, which takes into consideration both islet cell quality and quantity, may enable a more accurate and prospective evaluation of clinical islet preparations.

Indexed as

Oxygen ConsumptionAdultArea Under CurveBody WeightCell MembraneDNAFemaleHumansImmunosuppressive AgentsInsulinIslets of LangerhansIslets of Langerhans TransplantationMalePancreatectomyPancreatitisROC CurveDNAImmunosuppressive AgentsInsulin

Identifiers

PMID26258815
PMCPMC4530873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.